Bipolar patients display stoichiometric imbalance of gene expression in post-mortem brain samples.
Asbjørn HolmgrenIbrahim A AkkouhKevin Sean O'ConnellJordi Requena OsetePål Marius BjørnstadSrdjan DjurovicTimothy HughesPublished in: Molecular psychiatry (2024)
Bipolar disorder is a severe neuro-psychiatric condition where genome-wide association and sequencing studies have pointed to dysregulated gene expression as likely to be causal. We observed strong correlation in expression between GWAS-associated genes and hypothesised that healthy function depends on balance in the relative expression levels of the associated genes and that patients display stoichiometric imbalance. We developed a method for quantifying stoichiometric imbalance and used this to predict each sample's diagnosis probability in four cortical brain RNAseq datasets. The percentage of phenotypic variance on the liability-scale explained by these probabilities ranged from 10.0 to 17.4% (AUC: 69.4-76.4%) which is a multiple of the classification performance achieved using absolute expression levels or GWAS-based polygenic risk scores. Most patients display stoichiometric imbalance in three to ten genes, suggesting that dysregulation of only a small fraction of associated genes can trigger the disorder, with the identity of these genes varying between individuals.
Keyphrases
- gene expression
- end stage renal disease
- bipolar disorder
- ejection fraction
- newly diagnosed
- genome wide
- chronic kidney disease
- poor prognosis
- prognostic factors
- dna methylation
- peritoneal dialysis
- mental health
- genome wide identification
- genome wide association
- major depressive disorder
- multiple sclerosis
- deep learning
- resting state
- functional connectivity
- brain injury